Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Randomised, Double-blind, Placebo Controlled Phase III Study of Subcutaneously Administered Onercept in the Treatment and Re-treatment of Subjects With Moderate to Severe Plaque Psoriasis

NCT00090129 is registered in ClinicalTrials.gov with EMD Serono as lead sponsor.

NCT NCT00090129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00090129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Randomised, Double-blind, Placebo Controlled Phase III Study of Subcutaneously Administered Onercept in the Treatment and Re-treatment of Subjects With Moderate to Severe Plaque Psoriasis
Lead sponsor
EMD Serono
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2004
Completion date
June 30, 2005
Enrollment
854 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, psoriatic